FLUVAC EV-03

France
|
2016-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Influenza virus
  • Streptococcus pneumoniae
  • Influenza-like illness/Acute respiratory infection
  • Pharmacological intervention
  • Vaccination